Press Releases

BRIDGEWATER, N.J., Feb. 3, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced positive top-line results from its global, randomized, double-blind placebo-controlled Phase 2 WILLOW study evaluating the efficacy, safety, and pharmacokinetics of INS1007 admin

DUBLIN, Feb. 3, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from treatment with BOTOX® (onabotulinumtoxinA) for pediatric upper limb spasticity. BOTOX® is approved to treat increased muscle stiffness in children 2

WOONSOCKET, R.I., Feb. 3, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced upcoming changes to its Board of Directors (the "Board"). Richard "Dick" Swift, Richard Bracken and Mark Bertolini will not stand for reelection at the company's 2020 Annual Meeting. The Board will then be reduced from 16 to

HOUSTON, Feb. 3, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that its open label, single arm US Phase 1 trial met its primary objective of demonstrating the safety of Liposomal Annamycin ("A

CHICAGO, Feb. 3, 2020 /PRNewswire/ -- Mark C. Hutten, DDS, MS, FACP, was sworn in as the president-elect of the American College of Prosthodontists (ACP) at the organization's 49th Annual Session held in Miami, Oct. 30 to Nov. 2, 2019.

FOLSOM, Calif., Feb. 3, 2020 /PRNewswire/ -- The California Walnut Commission announced today the launch of "The Power of 3" global marketing initiative, the first campaign of its scale aiming to educate consumers about how eating walnuts is a simple way to boost overall nutrition, worth sharing with friends and family in the spirit of love this February. The program wi

SPRINGDALE, Ark., Feb. 3, 2020 /PRNewswire/ -- Therapon Skin Health, the makers of the medical grade skincare line Theraderm® Clinical Skin Care, unvei

SEATTLE, Feb. 3, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced its intent to raise $60 million through a fully bac

Achievement increases total production capacity available to serve international medical markets by 230% Brings Aurora's total number of EU GMP certified Canadian production facilities to 3 Pharmacies in Germany have been instructed to resume sales of Aurora's suite of medical cannabis following temporary pause

SEATTLE, Feb. 3, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that following a meeting with the U.S. Food and Drug Administration ("FDA" or "the Agency"),